Difarmex SA
The score of Difarmex shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +6 % Total assets -9 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Difarmex's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Apr 2026
- Year ended 31 Dec 2024filed on 15 May 2025
- Year ended 31 Dec 2023filed on 08 May 2024
- Year ended 31 Dec 2022filed on 23 May 2023
- Year ended 31 Dec 2021filed on 09 Jun 2022
Difarmex's financial analysis
- Solvency69.3%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Difarmex
Difarmex's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0453.209.833
- VAT number
- BE0453209833
- Peppol
- Not found on Peppol as of 09 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 05 Aug 1994
- Registered office
- 3570 Alken
- Latest accounts
- 2025 · filed on 30 Apr 2026
- Activity
- Rental and operating of own or leased residential real estate, except social housing (NACE 68201)
Difarmex (SA) has been based in Alken since 1994, active in: rental and operating of own or leased residential real estate, except social housing. For 2025, it reports a net loss of 4,091 € and equity of 200,895 €; its revenue is not published. Its solvency stands at 69.3%, above the median of its sector (44.0%).
Companies similar to Difarmex
Companies in the same business, of comparable size and area, outside its group.
- Immo Chantry Tournai · balance sheet 290,031 €
- Ternada Support activities for petroleum and natural gas extraction Éghezée · balance sheet 289,926 €
- Linda Beckers Verzorging AAN Huis Beringen · balance sheet 290,112 €
- Laurane Lallemand Oncologie Andenne · balance sheet 290,144 €
- Amadri Forest · balance sheet 290,205 €
- Cabinet Médical D.Clermont Liège · balance sheet 289,955 €
Frequently asked questions about Difarmex
What is the revenue of Difarmex?
Difarmex files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Difarmex?
In Belgium, the VAT number is the company number prefixed with BE: BE0453209833 for Difarmex, if the company is VAT-registered. Its company number (CBE) is 0453.209.833.
Where is the registered office of Difarmex?
According to the CBE register, the registered office of Difarmex is in 3570 Alken.
What is the equity of Difarmex?
At the close of the 2025 financial year, the equity of Difarmex amounts to 200,895 €, a solvency of 69.3% of total assets.
Who manages Difarmex?
The register lists 3 active mandates at Difarmex. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Difarmex
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →